5th Joint Transnational Call for Proposals (2022)

Basic Information

With its fifth transnational call (non-cofunded by the EC), ERA PerMed aims to foster research in prevention in personalised medicine. The overarching goal of the call is the development of tailor-made strategies for prevention of disease and disease progression, at three different levels: i. preventive measures decreasing the rate of incidence (primary prevention), ii. early detection to increase the efficacy of a preventive therapy, even before symptoms are developed (secondary prevention), and iii. interventions preventing disease recurrence or improving patients’ care and quality of life (tertiary prevention). Research on prevention from over-treatment or overmedicalisation in primary, secondary and tertiary personalised preventive approaches is optional and could be part of research proposals, if applicable. The clinical relevance of the proposed PM approach needs to be convincingly demonstrated.

Network

ERA PerMed

Website

https://erapermed.isciii.es/joint-calls/joint-transnational-call-2022/

Aim of the joint call

The overall objectives of the call are to: • Support translational research projects in the field of personalised medicine; • Encourage and enable interdisciplinary collaborations towards implementation of PM, in combining pre-clinical or clinical research with bio-informatics components as well as ELSA research or implementation research, including health economics; • Encourage collaboration between academia (research teams from universities, higher education institutions, public research institutions, research centres), clinical/public health research (research teams from hospital/ public health, healthcare settings and other healthcare organisations), private partners e.g. SMEs (small and medium-sized enterprises) as well as policy makers, regulatory/HTA agencies and patient organisations.

Type of joint call

Two Stages - Call with pre-proposals and full proposals submissions

Events

-                                                Launch date
+/12/2021
-                                                Deadline Pre-Proposal
+/02/2022 Submitted proposal: 174
-                                                Deadline Full-Proposal
+/06/2022 Submitted proposal: 60
-                                                Evaluation End Date
+/09/2022
                                                Successful proposal: 24
                                                Proposals funded: 24

Is call co-funded?

Call follow up funding

There are mechanisms in place to monitor

Call reasons

Achieving critical mass
Sharing competences and associated work
Addressing global issues
Access to expertise from different countries
Addressing specific scientific and technological issues

Research fields

Biotechnology
Health
Information and communication technologies
Socio-economics sciences and humanities

Type of research

Basic research
Applied Research

Target groups

Higher Education Institutions (HEIs)
Public Research Organisations (PROs)
Private and Semi-private Research and Technology Organisations (RTOs)
SME (Small and Medium Enterprises)
Other: Patient organisations

Participating networks

n/a

Organisations Participating

Show on map

Country	Organisation
Austria	Austrian Science Fund (FWF)
Belgium	National Fund for Scientific Research (FNRS)
Brazil	Brazilian National Council for the State Funding Agencies (CONFAP)
Canada	Quebec Research Fund - Health (FRQS)
Chile	National Research and Development Agency (ANID)
Croatia	Ministry of Science, Education and Sports (MSES-MZOS)
Denmark	Innovation Fund Denmark (Innofond)
Estonia	Estonian Science Foundation (ETAG)
France	National Research Agency (ANR)
Germany	Federal Ministry of Education and Research (BMBF)
Germany	Federal Ministry of Health (BMG)
Germany	Saxon State Ministry for science, culture and tourism (SMWK)
Hungary	National Research, Development and Innovation Office (NKFIH)
Ireland	Health Research Board (HRB)
Israel	Ministry of Health (CSO-MOH)
Italy	Lombardy Foundation for Biomedical Research (FRRB)
Italy	Ministry of Health (MOH/MDS)
Italy	Tuscany Region (TOS)
Latvia	State Education Development Agency (VIAA)
Lithuania	Research Council of Lithuania (LSC/LMT/RCL)
Luxembourg	National Fund for Research (FNR)
Norway	Research Council of Norway (RCN)
Poland	National Centre for Research and Development (NCBiR)
Romania	Executive Agency for Higher Education, Research, Development and Innovation Funding (UEFISCDI)
Slovenia	Ministry of Education, Science, Culture and Sport (MESCS/MIZS)
South Africa	South African Medical Research Council (SAMRC)
Spain	DEPARTMENT OF HEALTH - GOVERNMENT OF CATALONIA (DDS-GDC)
Spain	Government of Navarra (CFN)
Spain	Institute of Health Carlos III (ISCIII)
Spain	Spanish Association Against Cancer Scientific Foundation (AECC FC)
Sweden	Swedish Governmental Agency for Innovation Systems (VINNOVA)
Taiwan	National Science and Technology Council / Ministry of Science and Technology (NSTC / MoST Taiwan)
Türkiye	The Scientific and Technological Research Council of Turkey (TUBITAK)

Funded Projects

Acronym	Title	Start	End	No. partners
BIPCOM	MEDICAL COMORBIDITIES IN BIPOLAR DISORDER: CLINICAL VALIDAT...	01/02/2023	31/01/2026	8
DAWN-AF	Digital Twins to Treat Atrial Fibrillation	01/03/2023	28/02/2026	6
DEEPEN-iRBD	Prodromal DEtErminants for PhENoconversion of idiopathic RBD...	01/02/2023	31/01/2026	8
ETAP	Early diagnosis and personalized Therapy in Autism spectrum ...			5
Glioma-PerMed	Glioma invasion assays as a predictive tool for personalized...			5
IPerGlio	Improving personalised glioblastoma care by intertwined immu...	01/05/2023	30/04/2026	6
KidneySign	An integrated multi-omics signature of kidney fibrosis for C...	02/05/2023	01/05/2026	6
LANTERN	CANCER MULTI-OMICS AVATARS FOR INTEGRATED PRECISION MEDICINE	01/04/2023	31/03/2026	6
MG-PerMed	Personalising myasthenia gravis medicine: from “one-fits-all...	01/03/2023	28/02/2026	6
ONAKI-ICI	Towards a personalized clinical management of oncologic pati...	01/04/2023	31/03/2026	7
OPTIMA	Omics Approach for Personalized Prevention of Type 2 Diabete...	01/05/2023	30/04/2026	4
OVA-PDM	Personalizing the clinical decision making in ovarian cancer...	01/04/2023	31/03/2026	6
OmegaPerMed	Optimizing omega-3 supplementation to resolve inflammation i...	01/01/2023	31/12/2025	5
PARADISE	PersonAlisation of RelApse risk in autoimmune DISEase	03/04/2023	02/04/2026	8
PERMANENS	Towards Personalised Clinical Management of Suicide Risk thr...	01/03/2023	28/02/2026	5
PERMEPSY	Towards a personalized medicine approach to psychological tr...	01/05/2023	30/04/2026	6
PORTRAIT	A multi-omic stratification and a non invasive tool for earl...			7
RELIABLE	Targeting subclinical motor and cognitive impairment in pati...	01/03/2023	28/02/2026	4
SIGNAL	Body fluid proteome SIGnatures for persoNALised intervention...	01/05/2023	30/04/2026	6
SPAREKID	MULTI-MARKERS RISK ASSESSMENT OF KIDNEY SENSITIVITY TO INJUR...	20/03/2023	19/03/2026	6
Stracyfic	Patient Stratification by Standardization of the Image-based...	01/06/2023	31/05/2026	5
UBIOBCA	Urine biomarkers for bladder cancer initial detection and su...	01/05/2023	30/04/2026	5
UriCoV	Urinary peptidomic patterns of Long-COVID syndrome	01/03/2023		7
miRPOC	miRNA as biomarkers in early detection and personalized trea...			4